These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

845 related items for PubMed ID: 21982571

  • 1. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [Abstract] [Full Text] [Related]

  • 2. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM, Jammaz IA.
    Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
    [Abstract] [Full Text] [Related]

  • 3. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
    Fragogeorgi EA, Zikos C, Gourni E, Bouziotis P, Paravatou-Petsotas M, Loudos G, Mitsokapas N, Xanthopoulos S, Mavri-Vavayanni M, Livaniou E, Varvarigou AD, Archimandritis SC.
    Bioconjug Chem; 2009 May 20; 20(5):856-67. PubMed ID: 19344122
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    Shan L.
    ; 2004 May 20. PubMed ID: 22514805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo evaluation of a 64Cu-labeled polyethylene glycol-bombesin conjugate.
    Rogers BE, Manna DD, Safavy A.
    Cancer Biother Radiopharm; 2004 Feb 20; 19(1):25-34. PubMed ID: 15068608
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
    Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Pili R, Pomper M, Carducci M, Wagner HN.
    Bioconjug Chem; 2004 Feb 20; 15(6):1416-23. PubMed ID: 15546210
    [Abstract] [Full Text] [Related]

  • 12. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ, Maina T, Sallegger W, Krenning EP, de Jong M, Nock BA.
    J Nucl Med; 2013 Oct 20; 54(10):1797-803. PubMed ID: 24009275
    [Abstract] [Full Text] [Related]

  • 13. PEGylation, increasing specific activity and multiple dosing as strategies to improve the risk-benefit profile of targeted radionuclide therapy with 177Lu-DOTA-bombesin analogues.
    Däpp S, Müller C, Garayoa EG, Bläuenstein P, Maes V, Brans L, Tourwé DA, Schibli R.
    EJNMMI Res; 2012 Jun 09; 2(1):24. PubMed ID: 22681935
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer.
    Yu Z, Carlucci G, Ananias HJ, Dierckx RA, Liu S, Helfrich W, Wang F, de Jong IJ, Elsinga PH.
    Amino Acids; 2013 Feb 09; 44(2):543-53. PubMed ID: 22833158
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N, Ferro-Flores G, Santos-Cuevas C, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Isaac-Olivé K, Camacho-López M, Torres-García E.
    J Labelled Comp Radiopharm; 2013 Nov 09; 56(13):663-71. PubMed ID: 25196028
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.